These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 33887686)

  • 1. Prospective experimental treatment of colorectal cancer patients based on organoid drug responses.
    Ooft SN; Weeber F; Schipper L; Dijkstra KK; McLean CM; Kaing S; van de Haar J; Prevoo W; van Werkhoven E; Snaebjornsson P; Hoes LR; Chalabi M; van der Velden D; van Leerdam M; Boot H; Grootscholten C; Huitema ADR; Bloemendal HJ; Cuppen E; Voest EE
    ESMO Open; 2021 Jun; 6(3):100103. PubMed ID: 33887686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medium-throughput Drug Screening of Patient-derived Organoids from Colorectal Peritoneal Metastases to Direct Personalized Therapy.
    Narasimhan V; Wright JA; Churchill M; Wang T; Rosati R; Lannagan TRM; Vrbanac L; Richardson AB; Kobayashi H; Price T; Tye GXY; Marker J; Hewett PJ; Flood MP; Pereira S; Whitney GA; Michael M; Tie J; Mukherjee S; Grandori C; Heriot AG; Worthley DL; Ramsay RG; Woods SL
    Clin Cancer Res; 2020 Jul; 26(14):3662-3670. PubMed ID: 32376656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Precision medicine applied to metastatic colorectal cancer using tumor-derived organoids and in-vitro sensitivity testing: a phase 2, single-center, open-label, and non-comparative study.
    Jensen LH; Rogatto SR; Lindebjerg J; Havelund B; Abildgaard C; do Canto LM; Vagn-Hansen C; Dam C; Rafaelsen S; Hansen TF
    J Exp Clin Cancer Res; 2023 May; 42(1):115. PubMed ID: 37143108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient-derived organoids as a preclinical platform for precision medicine in colorectal cancer.
    Cho YW; Min DW; Kim HP; An Y; Kim S; Youk J; Chun J; Im JP; Song SH; Ju YS; Han SW; Park KJ; Kim TY
    Mol Oncol; 2022 Jun; 16(12):2396-2412. PubMed ID: 34850547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accuracy of Using a Patient-Derived Tumor Organoid Culture Model to Predict the Response to Chemotherapy Regimens In Stage IV Colorectal Cancer: A Blinded Study.
    Wang T; Pan W; Zheng H; Zheng H; Wang Z; Li JJ; Deng C; Yan J
    Dis Colon Rectum; 2021 Jul; 64(7):833-850. PubMed ID: 33709991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organoids as a Robust Preclinical Model for Precision Medicine in Colorectal Cancer: A Systematic Review.
    Flood M; Narasimhan V; Wilson K; Lim WM; Ramsay R; Michael M; Heriot A
    Ann Surg Oncol; 2022 Jan; 29(1):47-59. PubMed ID: 34596795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
    Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective derivation of a living organoid biobank of colorectal cancer patients.
    van de Wetering M; Francies HE; Francis JM; Bounova G; Iorio F; Pronk A; van Houdt W; van Gorp J; Taylor-Weiner A; Kester L; McLaren-Douglas A; Blokker J; Jaksani S; Bartfeld S; Volckman R; van Sluis P; Li VS; Seepo S; Sekhar Pedamallu C; Cibulskis K; Carter SL; McKenna A; Lawrence MS; Lichtenstein L; Stewart C; Koster J; Versteeg R; van Oudenaarden A; Saez-Rodriguez J; Vries RG; Getz G; Wessels L; Stratton MR; McDermott U; Meyerson M; Garnett MJ; Clevers H
    Cell; 2015 May; 161(4):933-45. PubMed ID: 25957691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preserved genetic diversity in organoids cultured from biopsies of human colorectal cancer metastases.
    Weeber F; van de Wetering M; Hoogstraat M; Dijkstra KK; Krijgsman O; Kuilman T; Gadellaa-van Hooijdonk CG; van der Velden DL; Peeper DS; Cuppen EP; Vries RG; Clevers H; Voest EE
    Proc Natl Acad Sci U S A; 2015 Oct; 112(43):13308-11. PubMed ID: 26460009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implementing patient derived organoids in functional precision medicine for patients with advanced colorectal cancer.
    Cartry J; Bedja S; Boilève A; Mathieu JRR; Gontran E; Annereau M; Job B; Mouawia A; Mathias P; De Baère T; Italiano A; Besse B; Sourrouille I; Gelli M; Bani MA; Dartigues P; Hollebecque A; Smolenschi C; Ducreux M; Malka D; Jaulin F
    J Exp Clin Cancer Res; 2023 Oct; 42(1):281. PubMed ID: 37880806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deciphering the Tumor Microenvironment of Colorectal Cancer and Guiding Clinical Treatment With Patient-Derived Organoid Technology: Progress and Challenges.
    Li J; Liu J; Xia W; Yang H; Sha W; Chen H
    Technol Cancer Res Treat; 2024; 23():15330338231221856. PubMed ID: 38225190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-Derived Cancer Organoid Cultures to Predict Sensitivity to Chemotherapy and Radiation.
    Pasch CA; Favreau PF; Yueh AE; Babiarz CP; Gillette AA; Sharick JT; Karim MR; Nickel KP; DeZeeuw AK; Sprackling CM; Emmerich PB; DeStefanis RA; Pitera RT; Payne SN; Korkos DP; Clipson L; Walsh CM; Miller D; Carchman EH; Burkard ME; Lemmon KK; Matkowskyj KA; Newton MA; Ong IM; Bassetti MF; Kimple RJ; Skala MC; Deming DA
    Clin Cancer Res; 2019 Sep; 25(17):5376-5387. PubMed ID: 31175091
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
    Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
    Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studying cellular heterogeneity and drug sensitivity in colorectal cancer using organoid technology.
    Sasaki N; Clevers H
    Curr Opin Genet Dev; 2018 Oct; 52():117-122. PubMed ID: 30261425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organoid Models of Colorectal Pathology: Do They Hold the Key to Personalized Medicine? A Systematic Review.
    DeHaan RK; Sarvestani SK; Huang EH
    Dis Colon Rectum; 2020 Nov; 63(11):1559-1569. PubMed ID: 32868555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer.
    Xie BY; Wu AW
    Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organoids from colorectal peritoneal metastases as a platform for improving hyperthermic intraperitoneal chemotherapy.
    Ubink I; Bolhaqueiro ACF; Elias SG; Raats DAE; Constantinides A; Peters NA; Wassenaar ECE; de Hingh IHJT; Rovers KP; van Grevenstein WMU; Laclé MM; Kops GJPL; Borel Rinkes IHM; Kranenburg O
    Br J Surg; 2019 Sep; 106(10):1404-1414. PubMed ID: 31197820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug screening by uniform patient derived colorectal cancer hydro-organoids.
    Jung YH; Choi DH; Park K; Lee SB; Kim J; Kim H; Jeong HW; Yang JH; Kim JA; Chung S; Min BS
    Biomaterials; 2021 Sep; 276():121004. PubMed ID: 34273688
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Organoid screening reveals epigenetic vulnerabilities in human colorectal cancer.
    Toshimitsu K; Takano A; Fujii M; Togasaki K; Matano M; Takahashi S; Kanai T; Sato T
    Nat Chem Biol; 2022 Jun; 18(6):605-614. PubMed ID: 35273398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection.
    Johnson KA; DeStefanis RA; Emmerich PB; Grogan PT; Kratz JD; Makkar SK; Clipson L; Deming DA
    Curr Treat Options Oncol; 2020 Apr; 21(5):35. PubMed ID: 32328818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.